Brookfield, CT, United States of America

Younggi Choi

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Younggi Choi. Retrieved from https://idiyas.com/inventor/younggi-choi-9ffoxhro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Younggi Choi: Innovator in Pharmaceutical Chemistry

Introduction

Younggi Choi is a notable inventor based in Brookfield, CT (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the body.

Latest Patents

Younggi Choi holds a patent for a compound titled "2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10." This invention relates to a compound of formula (I) and the pharmaceutically acceptable salts thereof, wherein R, R, R, Ar, and Het are as defined in the patent. The invention also encompasses methods of using this compound to treat diseases and disorders mediated or sustained through the activity of CCR10.

Career Highlights

Younggi Choi is currently employed at Boehringer Ingelheim International GmbH, where he continues to advance his research and development efforts. His work focuses on innovative solutions in the pharmaceutical industry, contributing to the creation of new therapeutic options.

Collaborations

Throughout his career, Younggi has collaborated with esteemed colleagues, including Craig Andrew Miller and Donghong Amy Gao. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Younggi Choi's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the field positively, paving the way for new treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…